Endologix
AcquiredPublic · $52.0M raised
- Website
- endologix.com
- Total Funding
- $52.0M
- Last Round
- $52.0M Venture RoundMar 2019
- Rounds
- 1
- Type
- Public
- Ticker
- ELGX · NASDAQ
- Acquisition Date
- Oct 2020
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Endologix is a Biotech company. It has raised $52.0M in total across 1 round, most recently a $52.0M Venture Round in Mar 2019. Investors include Deerfield Management.
Funding & Exit History
Oct 2020
Sign up to see all 3 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/endologix"><img src="https://indexed.vc/api/badge/company/endologix" alt="Endologix on Indexed.vc" width="260" height="76" /></a>